BKM120 (Buparlisib)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BKM120 (Buparlisib), covering 2015-09-17 to 2018-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme [Phase 1, Phase 2]